van der Veldt, Astrid A. M.
Oosting, Sjoukje F.
Dingemans, Anne-Marie C.
Fehrmann, Rudolf S. N.
GeurtsvanKessel, Corine http://orcid.org/0000-0002-7678-314X
Jalving, Mathilde
Rimmelzwaan, Guus F.
Kvistborg, Pia http://orcid.org/0000-0002-4988-608X
Blank, Christian U. http://orcid.org/0000-0002-7945-5846
Smit, Egbert F.
Lemmens, Valery E. E. P.
Hiltermann, T. Jeroen N. http://orcid.org/0000-0002-0665-2160
Koopmans, Marion P. G. http://orcid.org/0000-0002-5204-2312
Huckriede, Anke L. W.
Rots, Nynke Y.
van Els, Cecile A. C. M.
van Baarle, Debbie
Haanen, John B. A. G. http://orcid.org/0000-0001-5884-7704
de Vries, Elisabeth G. E. http://orcid.org/0000-0002-8949-7425
Article History
First Online: 15 February 2021
Competing interests
: A.A.M.v.d.V. reports consultancy fees (paid to Erasmus Medical Center) from BMS, MSD, Merck, Sanofi, Eisai, Pfizer, Ipsen, Roche, Pierre Fabre and Novartis. S.F.O. reports research grants from Novartis and Celldex Therapeutics (paid to University Medical Center Groningen). A.-M.C.D. reports consultancy fees (paid to Erasmus Medical Center) from Roche, Eli Lilly, Boehringer Ingelheim, BMS, Amgen, Novartis, Pfizer, Takeda, Chiesi, Pharmamar, Bayer and Sanofi, and research support (paid to Erasmus Medical Center) from BMS, AbbVie and Amgen. Mathilde Jalving reports consultancy fees (paid to University Medical Center Groningen) from BMS, MSD, Merck, Pfizer, AstraZeneca, Pierre Fabre and Novartis. C.U.B. reports an advisory role at BMS, MSD, Roche, Novartis, GSK, AZ, Pfizer, Lilly, GenMab, Pierre Fabre and Third Rock Ventures, research funding from BMS, Novartis and NanoString, and stock ownership in Uniti Cars, and is a co-founder of Immagene BV. E.F.S. reports consultancy fees (all Netherlands Cancer Institute–Antoni van Leeuwenhoek Hospital) from AstraZeneca, Bayer, Bristol Myers Squibb, Daiichi Sankyo, Eli Lilly, Merck, MSD, Novartis, Pfizer, Roche Diagnostics, Roche Genentech and Takeda. T.J.N.H. reports consultancy fees (paid to University Medical Center Groningen) from BMS, MSD, Merck, Boehringer, AstraZeneca and Roche. J.B.A.G.H. reports consultancy roles for Achilles Therapeutics, BioNTech, BMS, GSK, Immunocore, Molecular Partners, MSD, Merck Serono, Neogene Therapeutics, Novartis, Pfizer, Roche/Genentech, Sanofi and Third Rock Ventures, and research grants from Amgen, BMS, BioNTech, MSD, Novartis, Neogene Therapeutics (paid to the Netherlands Cancer Institute–Antoni van Leeuwenhoek Hospital). Elisabeth G.E. de Vries reports an advisory role at Daiichi Sankyo, NSABP and Sanofi (paid to University Medical Center Groningen), and research funding from Amgen, AstraZeneca, Bayer, Chugai Pharma, CytomX Therapeutics, G1 Therapeutics, Genentech, Nordic Nanovector, Radius Health, Regeneron, Roche, Servier and Synthon (paid to University Medical Center Groningen).
Free to read: This content has been made available to all.